Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Oarsman Capital Inc.

Oarsman Capital Inc. trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,383 shares of the medical equipment provider’s stock after selling 40 shares during the quarter. Oarsman Capital Inc.’s holdings in Intuitive Surgical were worth $722,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of ISRG. Norges Bank acquired a new position in shares of Intuitive Surgical in the fourth quarter worth $2,401,493,000. Proficio Capital Partners LLC boosted its stake in shares of Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after purchasing an additional 948,902 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $313,769,000. Wilmington Savings Fund Society FSB grew its stake in Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after acquiring an additional 552,058 shares during the period. Finally, Vanguard Group Inc. raised its holdings in Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after acquiring an additional 360,591 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 8.7 %

ISRG stock opened at $451.58 on Friday. The firm has a market cap of $160.84 billion, a P/E ratio of 70.45, a P/E/G ratio of 5.85 and a beta of 1.55. The stock’s 50 day simple moving average is $545.18 and its 200 day simple moving average is $532.30. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. Company insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several analyst reports. UBS Group upped their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Raymond James increased their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Royal Bank of Canada boosted their price target on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Robert W. Baird decreased their target price on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a report on Tuesday, March 18th. Finally, Bernstein Bank increased their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.